Related Experiment Video
Updated: Dec 30, 2025
08:07
Analysis of the Expression and Complexes Assembly of the Mitochondrial Respiratory Chain Proteins in the Fission Yeast Schizosaccharomyces pombe
Published on: May 2, 2025
828
Expression, purification, and crystallization of Schizosaccharomyces pombe eIF2B
Kazuhiro Kashiwagi1,2,3, Tomoaki Shigeta4, Hiroaki Imataka4
1Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Journal of Structural and Functional Genomics
|March 30, 2016
Summary
Researchers developed a method to produce the essential protein complex eukaryotic translation initiation factor 2B (eIF2B) in E. coli. This breakthrough allows for structural studies and understanding of related neurodegenerative diseases.
Area of Science:
- Molecular Biology
- Structural Biology
- Neuroscience
Background:
- Protein synthesis regulation is crucial for cellular adaptation.
- Eukaryotic translation initiation factor 2B (eIF2B) controls protein synthesis initiation.
- Dysfunction of eIF2B is linked to the neurodegenerative disease leukoencephalopathy with vanishing white matter.
Purpose of the Study:
- To establish a method for recombinant expression and purification of the eIF2B complex.
- To investigate the structure and function of eIF2B.
- To explore the impact of disease-linked mutations on eIF2B.
Main Methods:
- Co-expression and reconstruction of all five eIF2B subunits in E. coli.
- Purification of the eIF2B complex using high-yield methods.
- Size exclusion chromatography to determine complex stoichiometry and assembly.
- In vitro reconstitution of protein synthesis using the recombinant complex.
- Crystallization of the functional recombinant eIF2B complex.
Main Results:
- A functional, high-yield recombinant eIF2B complex was successfully produced.
- The complex exists as a heterodecamer with equimolar subunit ratios.
- Recombinant eIF2B enhanced protein synthesis in an in vitro system.
- Disease-associated mutations caused eIF2B subunit dissociation.
- Crystals of the functional eIF2B complex were obtained, diffracting to 3.0 Å resolution.
Conclusions:
- The established recombinant expression system overcomes previous limitations in obtaining eIF2B.
- The structural and functional characterization of eIF2B provides insights into its role in translation and disease.
- This work facilitates further structural studies of eIF2B and the development of potential therapeutic strategies for related neurodegenerative disorders.
